Skip to content

PT-141 vs TB-500: side-by-side comparison

Peptide

Bremelanotide · Vyleesi

A melanocortin agonist used for sexual dysfunction. FDA-approved (as Vyleesi) for hypoactive sexual desire disorder in premenopausal women; also used off-label by some men for sexual dysfunction, though it carries no FDA approval or official dosing guidance for that use.

1.0/10 natty
Full breakdown →
VS
Peptide

Thymosin Beta-4 · TB4 · TB 500

Focuses on systemic healing, cell migration, and flexibility. A naturally occurring peptide present in almost all human cells that plays a key role in tissue repair and regeneration.

1.0/10 natty
Full breakdown →

1 / 10 natty scale / 1

Same lane

Both sit in the same class and are run for health. This is a like-for-like comparison: read the gaps as real trade-offs.

The tape

Core ratings

The same three rulers every entry on the site is scored with, read head to head.

PT-141TB-500
1.0

Natty scale

1 natural · 10 heavy

1.0
3.5

Effectiveness

Documented effect · of 5Δ1

4.5
2.5

Side-effect severity

Documented burden · of 5Δ1.5

1.0

Cost side

Body-load fingerprint

Where each one actually lands its strain, on the calculator's thirteen channels. Tap a row for what it means and which labs track it.

PT-141TB-500

Cardiometabolic

Organ strain

Systemic

Injection & site care

Bars show strain at each one's typical protocol, not your dose. marks values inferred from side-effect data or category rather than hand-graded. For your numbers, run the calculator.

Logistics

The vitals

PT-141TB-500
Peptide
Classmatch
Peptide
Subcutaneous
Routematch
Subcutaneous
0.5-4 mg/dayAs-needed subcutaneous injection, at least 45 minutes before anticipated sexual activity (FDA label). Approved maximum: 1 dose per 24 hours, no more than 8 doses per month. Off-label users often self-limit further (e.g. 2-3x/week) to manage nausea/blood-pressure effects.
Typical dose
2-6 mg/week2x/week during a 4-6 week loading phase, then often reduced to 1x/week for maintenance
~2.7 hours (range 1.9-4.0 hours)
Half-life
~2-3 hours
8-26 weeks
Typical run
6-12 weeks
Prescription only
Legal status
Research chemical
Not prohibited
WADA
ProhibitedS2. Peptide Hormones, Growth Factors, Related Substances and Mimetics

Benefit side

What each is for

Shared goals carry both dots; a goal with one dot belongs to that side alone.

PT-141TB-500
HealthRecovery

Run for

Sexual DesireIncreases libido and sexual desire in both men and women.
Erectile FunctionMay support erectile function via central-nervous-system action, and showed an enhanced response when combined with low-dose sildenafil in a small trial, though standalone development for male erectile dysfunction was discontinued after the FDA raised blood-pressure concerns over the intranasal formulation.
Female Sexual DysfunctionFDA-approved for hypoactive sexual desire disorder in premenopausal women.

Documented upside

  • Increased sexual desire
  • Works on desire, not just function
  • Clinically validated (FDA-approved) efficacy in women; also used off-label by men
  • FDA-approved
  • May complement PDE5 inhibitors via a different (central) mechanism

Run for

Systemic HealingPromotes healing throughout the body, not just at injection site.
FlexibilityImproves tissue flexibility and reduces adhesions.
Inflammation ReductionPowerful anti-inflammatory effects.

Documented upside

  • Systemic healing effects
  • Reduced inflammation
  • Improved flexibility
  • Enhanced wound healing
  • Promotes new blood vessel formation
+1 more on the full page

The downsides

Side effects, aligned

Each entry's documented side effects, sorted onto the same body systems so the gaps and the overlaps are visible. Tap any effect for the detail.

PT-141TB-500
Blood pressure & water

None documented

Injection site

None documented

Other documented effects

The exit

Hormonal fallout & recovery

What each does to your own hormone axis while on, and what leaving it costs.

PT-141TB-500
Not required
PCT
Not required
Support role
What sticks
While-on only

PT-141

Not hormonal in the traditional sense. No PCT required.

TB-500

Does not affect hormones. No PCT required.

Read-out

How they separate

  1. 01

    Enhancement

    They land at almost the same point on the natty scale (1/10 vs 1/10): a similar distance beyond natural.

  2. 02

    Side-effect bill

    PT-141's documented side-effect severity is heavier (2.5/5 vs 1/5). The body-load fingerprint above shows where that weight actually lands.

  3. 03

    Body load

    The widest gap at typical protocols is heart structure (PT-141 4/10 vs 0/10), then blood pressure (PT-141 4/10 vs 0/10).

  4. 04

    Coming off

    Neither requires PCT: both leave the natural testosterone axis running.

  5. 05

    Logistics

    typical runs are 8-26 weeks vs 6-12 weeks.

  6. 06

    Tested athletes

    TB-500 is WADA-prohibited; PT-141 is not on the prohibited list.

Generated from each entry's data file. Descriptive, not a recommendation; nothing here is medical advice.